contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


modulight-laser-company-being-calibrated-towards-growth

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Analyst

Antti Siltanen

Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.

Här är en ny högkvalitativ och bra analys av Modulight.  Modulight’s Q3 report showed no clear signs of a return to growth and revenue landed below expectations. Earnings and cash flow were roughly in line with our forecasts due to lower-than-expected costs. We are lowering our growth and cost forecasts for the coming years, while the business turnaround is still to come. We reiterate our Reduce recommendation and target price of EUR 0.9.                   Inderes              Modulight Q3'24: No clear signs of growth yet - Inderes    Modulight's Q3 report showed no clear signs of a return to growth and revenue landed below expectations. Earnings and cash flow were roughly in line with our forecasts due to lower-than-expected costs.

Modulights Q3-resultat var lägre än förväntat när det gäller omsättningen, även om vinsten och kassaflödet var i linje med prognoserna. Omsättningen påverkades negativt av övergången till PPT-modellen och förseningar i prototypleveranser. Utsikterna för 2024 verkar vara under målen, och rapporten visade ännu inga tecken på tillväxt.                   Inderes              Modulight Q3'24 flash comment: Revenue missed expectations - profit and cash...    Modulight's revenue was well below our expectations, but profit and cash flow were close to our forecasts. Revenue was negatively impacted by the transition to the PPT (pay-per-treatment) model and delays in prototype deliveries.

Modulights Q3-resultat under förväntningarna – intäkterna påverkades av förändringar i intäktsmodellen och leveransförseningar Modulight offentliggjorde på fredagen sitt resultat för tredje kvartalet, där intäkterna var klart lägre än förväntat. Bolagets vinst och kassaflöde motsvarade däremot prognoserna. Intäkterna påverkades negativt av övergången till PPT (pay-per-treatment)-modellen samt förseningar i prototypleveranser. Bolagets utsikter för 2024 ser ut att bli sämre än både bolagets egna och marknadens mål. En webcast hålls på måndag kl. 14.30 EEST för en närmare analys av resultatet, och vi uppdaterar våra bedömningar senast på tisdag. Hittills har rapporten inte visat några tydliga tecken på en återgång till tillväxt.                   Inderes              Modulight Q3'24 flash comment: Revenue missed expectations - profit and cash...    Modulight's revenue was well below our expectations, but profit and cash flow were close to our forecasts. Revenue was negatively impacted by the transition to the PPT (pay-per-treatment) model and delays in prototype deliveries.

Here is a high-quality and free analysis of Modylight.                    Inderes              Modulight: 2023 landed below targets - Inderes    Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company's own targets.                             Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company’s own targets. We are revising our forecasts for the coming years moderately downwards with the visibility being very low. With the forecast cuts, the stock still looks expensive both in absolute terms and relative to peers. In the coming year, new commercializations can give greater visibility to the company’s future.

Modulight står inför en stenig väg. Trots att marknaden är defensiv och inriktad på framtiden, har den projektbaserade modellen visat sig vara opålitlig, och dess långsiktiga funktionalitet kräver fortfarande bevis. Att förutse omsättning och lönsamhet är som att spela tärning, och synligheten i projekten är alarmerande svag. Kundbasens omognad och koncentration lägger ytterligare tryck, vilket ökar risknivån ytterligare. För Modulight väntar uppenbarligen stormiga vatten. Eller finns det något speciellt med det här företaget som har fått dig eller någon annan att bli intresserad? Tack för svaret redan på förhand!  Jag är mycket dåligt bekant med det här företaget.

Here is a really good analysis.  “The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company’s revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in this quarter. We are lowering our estimates for the short and long term in view of the difficulties in the business and the continuing very low visibility. Despite the fall in the share price, the valuation seems even more challenging than before, as in addition to our estimates, our view on the acceptable multiples for the stock has gone down.”                   Inderes — Connecting Investors and Companies              Modulight: Growth not picking up yet    The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company's revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in...

Modulight: Positiv utveckling fortsatte, uppstarten av verksamhet på lokal nivå i USA framskred väl.                    Modulight Corporation              Modulight, Inc.

Modulight

Modulight is a technology company focused on the design and manufacture of lasers and optics with a strategic focus on medical and biomedical applications. Modulight's growth story was interrupted...

<p>Modulight is a technology company focused on the design and manufacture of lasers and optics with a strategic focus on medical and biomedical applications. Modulight's growth story was interrupted after the 2021 IPO and the company is now looking to get back on track for profitable growth with a renewed strategy. We expect the company to deliver strong growth, although the visibility of the forecast is weak. Our valuation that relies on sales-based ratios and cash flows suggests the stock being moderately overvalued. </p> 

	2022	23e	24e
Revenue	4.6	9.5	12.8
growth-%	-49.30 %	107.43 %	34.04 %
EBIT (adj.)	-7.8	-3.9	-2.6
EBIT-% (adj.)	-169.49 %	-40.45 %	-20.40 %
EPS (adj.)	-0.20	-0.09	-0.06
Dividend	0.00	0.00	0.00
Dividend %
P/E (adj.)	-	-	-
EV/EBITDA	-	-	200.24

Modulight: Laser company being calibrated towards growth

Modulight

Key Estimate Figures2023-03-20

Modulight

Key Estimate Figures2023-03-20

Stay up to date with our newsletter